Patient preferences for treatment of multiple sclerosis with disease-modifying therapies: a discrete choice experiment

Por Garcia-Dominguez, José Manuel, Muñoz, Delicias, Comellas, Marta, Gonzalbo, Irmina, Lizán, Luis, Polanco Sánchez, Carlos
Publicado no Patient Prefer Adherence (2016)

Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers

Por Muñoz, Delicias, Escartín, Antonio, Dapena, Dolores, Coret, Francisco, Fernández-Uría, Dionisio, Pérez, Domingo, Casanova, Bonaventura, Guijarro-Castro, Cristina, Munteis, Elvira, del-Campo Amigo, María, Pego, Robustiano, Calles, Carmen, García-Rey, César, Monsalve, Nuria, Sánchez-Matienzo, David
Publicado em 2013

Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial

Por Villoslada, Pablo, Rovira, Alex, Montalban, Xavier, Arroyo, Rafael, Paul, Friedemann, Meca-Lallana, Virginia, Ramo, Cristina, Fernandez, Oscar, Saiz, Albert, Garcia-Merino, Antonio, Ramió-Torrentà, Lluís, Casanova, Bonaventura, Oreja-Guevara, Celia, Muñoz, Delicias, Martinez-Rodriguez, Jose Enrique, Lensch, Eckart, Prieto, Jose Maria, Meuth, Sven G., Nuñez, Xavier, Campás, Clara, Pugliese, Marco
Publicado no Neurol Neuroimmunol Neuroinflamm (2015)